By Kyle J. Norton
Health article writer and researcher; Over 10.000
articles and research papers have been written and published on line,
including world wide health, ezine articles, article base, healthblogs,
selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by
Disilgold.com Named 50 of the best health Tweeters Canada - Huffington
Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as
international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome
is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles
clumping on the ovaries that interferes with the function of the normal
ovaries associated
with a high risk for metabolic disorder(1) as resulting of enlarged
ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight
gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1
in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Herbal Medicine Perspective
The prevention and management
Polycystic
ovary syndrome (PCOS) is unpreventable in Western medicine. Early
diagnosis and treatment may reduce risk of its complications, including
infertility, metabolic syndrome, obesity, diabetes, cardiovascular
diseases, stroke, etc.
Reduce fat intake less than
30% of total calories with a low
proportion of saturated fat and high in fiber from predominantly
low-glycaemic-index-carbohydrate foods for patients with PCOs(827a). Calorie intake
should be distributed between several meals
per day with restricted intake of snacks and drinks(828).
The stress management herbs
Stress
in a natural reaction of human fight or fight response induced by
pressure due to environmental condition or a stimulus. Long
term stress can cause deleterious and cumulative effects on human
body(1104), including emotional or cognitive problems, such as an
increased risk of attentional deficit/hyperactivity, anxiety, and
language delay(1103), especially for people with chronic illness,
including women with Polycystic Ovarian Syndrome (PCOs)(1105).
Ashwagandha (Withania somnifera)
Ashwagandha(Withania
somnifera), also known as Indian Ginseng is a nightshade plant
belongings to the family Solanaceae, native to India, northern Africa,
and the Middle East, used in Ayurvedic medicine
over 3000 years(1101) as antitumors(1107)(1108), anti ulcers(1111),
anti-stress(1112)(1115)(1118), improved
cognition dysfunction(1109)(1110)(1118), anti-inflammatory(1113)(1116),
antioxidant(1114)(1117), promoted immunity(1120)(1121), anti-aging(1119),
etc., herbal medicine.
Phytochemicals(1102)
1. Isopelletierine
2. Anaferine
3. Cuseohygrine
4. Anahygrine
5. Withanolides
6. Withaferins
7. Saponins
8. Sitoindosides
9. Acylsterylglucosides
10. Z-Guggulsterone(1106)
10. Etc.
Epidemiologically strong evidences suggested that herbal ashwagandha
processes anti stress related disorders( induced by oxidative
stress(1122)(1123) and long term stress(1123) effects, probably through
its antioxidant(1123)(1124)(1126)(1114)(1117),
anti-stress(1112)(1115)(1118), anti-inflammatory(1113)(1116), immunomoduratory(1120)(1121) effects. In rat model, hydroalcoholic
extract exerted its antioxidant effect against psychological
symptoms(1132) induced by long term stress, such as reduced motor
performance(1124), cognitive impairment(1125)(1126, anxiety(1127)(1128),
sleep disorder(1129)(1130), depression(1131), etc. In stress induced by phyisological
symptoms, the herb has showen to reduce fatigue(1133) risk of
hypertension(1134), risk of stroke(1135). risk of diabetes(1136),
improve energy(1132), etc.
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome:
a complex condition with psychological, reproductive and metabolic
manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1,
Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A,
Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael
C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed)
(1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1101) Steroidal lactones from Withania somnifera, an ancient plant for novel medicine by Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J.(PubMed)
(1102)
An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda by
Narendra Singh, Mohit Bhalla, Prashanti de Jager, and Marilena Gilca(PubMed)
(1103) Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? by Talge NM1, Neal C, Glover V; Early Stress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health.(PubMed)
(1104) Immediate and long-term effects of meditation on acute stress reactivity, cognitive functions, and intelligence by Singh Y1, Sharma R, Talwar A.(PubMed)
(1105) The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage by Hart R1, Doherty DA.(PubMed)
(1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1107) Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses by Widodo N1, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R.(PubMed)
(1108) Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect by Widodo N1, Kaur K, Shrestha BG, Takagi Y, Ishii T, Wadhwa R, Kaul SC.(PubMed)
(1109) Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants by Pingali U1, Pilli R1, Fatima N1.(PubMed)
(1110) Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder by Chengappa KN1, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R.(PubMed)
(1111) Evaluation of the anti-ulcer activity of NR-ANX-C (a polyherbal formulation) in aspirin & pyloric ligature induced gastric ulcers in albino rats by Nair V1, Arjuman A, Gopalakrishna HN, Dorababu P, Mirshad PV, Bhargavan D, Chatterji D.(PubMed)
(1112) Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats by Khan MA, Subramaneyaan M, Arora VK, Banerjee BD, Ahmed RS.(PubMed)
(1113) Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats by Gupta A1, Singh S.(PubMed)
(1114) Protective effect of Withania
somnifera root powder in relation to lipid peroxidation, antioxidant
status, glycoproteins and bone collagen on adjuvant-induced arthritis in
rats by Rasool M1, Varalakshmi P.(PubMed)
(1115) Withania somnifera Improves Semen Quality in Stress-Related Male Fertility by Mahdi AA1, Shukla KK, Ahmad MK, Rajender S, Shankhwar SN, Singh V, Dalela D.(PubMed)
(1116) Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation by SoRelle JA1, Itoh T, Peng H, Kanak MA, Sugimoto K, Matsumoto S, Levy MF, Lawrence MC, Naziruddin B.(PubMed)
(1117) Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers by Kuchewar VV1, Borkar MA2, Nisargandha MA3.(PubMed)
(1118) Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis by Durg S1, Dhadde SB, Vandal R, Shivakumar BS, Charan CS.(PubMed)
(1119) In vitro protective effects of Withania
somnifera (L.) dunal root extract against hydrogen peroxide and
β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells by Kumar S1, Seal CJ, Howes MJ, Kite GC, Okello EJ.(PubMed)
(1120) Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice by Kushwaha S1, Roy S, Maity R, Mallick A, Soni VK, Singh PK, Chaurasiya ND, Sangwan RS, Misra-Bhattacharya S, Mandal C.(PubMed)
(1121) Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity by Khan S1, Malik F, Suri KA, Singh J.(PubMed)
(1122) Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha by Kaur K1, Rani G, Widodo N, Nagpal A, Taira K, Kaul SC, Wadhwa R.(PubMed)
(1123) Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum by Bhattacharya A1, Ghosal S, Bhattacharya SK.(PubMed)
(1124) Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats by Chaudhary G1, Sharma U, Jagannathan NR, Gupta YK.(PubMed)
(1125) Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somnifera by Yadav CS1, Kumar V, Suke SG, Ahmed RS, Mediratta PK, Banerjee BD.(PubMed)
(1126) Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment by Ahmed ME1, Javed H, Khan MM, Vaibhav K, Ahmad A, Khan A, Tabassum R, Islam F, Safhi MM, Islam F.(PubMed)
(1127) An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera) by Pratte MA1, Nanavati KB, Young V, Morley CP.(PubMed)
(1128) Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence by Sarris J1, McIntyre E, Camfield DA.(PubMed)
(1129) Effect of Withania somnifera on Sleep-Wake Cycle in Sleep-Disturbed Rats: Possible GABAergic Mechanism by Kumar A1, Kalonia H.(PubMed)
(1130) Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleep-disturbed mice (Grid over water suspended method) by Kumar A1, Kalonia H.(PubMed)
(1131) Protective effect of Withania somnifera dunal root extract against protracted social isolation induced behavior in rats by Gupta GL1, Rana AC.(PubMed)
(1132) An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda by Singh N1, Bhalla M, de Jager P, Gilca M.(PubMed)
(1133) Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients by Biswal BM1, Sulaiman SA, Ismail HC, Zakaria H, Musa KI.(PubMed)
(1134) Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension by Kaur G1, Singh N, Samuel SS, Bora HK, Sharma S, Pachauri SD, Dwivedi AK, Siddiqui HH, Hanif K.(PubMed)
(1135) Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis by Raghavan A1, Shah ZA.(PubMed)
(1136) The aqueous extract of Withania coagulans fruit partially reverses nicotinamide/streptozotocin-induced diabetes mellitus in rats by Shukla K1, Dikshit P, Shukla R, Gambhir JK.(PubMed)
No comments:
Post a Comment